Drug profile · INN
tuvonralimab
tuvonralimab is an FDA-listed pharmaceutical active ingredient.
NMPA: clinical trials
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — tuvonralimab
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.70
Quick answer
tuvonralimab is an FDA-listed pharmaceutical active ingredient.
Key facts
INN tuvonralimab
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
- Iparomlimab and Tuvonralimab Injection (QL1706)
- Iparomlimab and Tuvonralimab Injection (QL1706)
- Iparomlimab and Tuvonralimab Injection in combination with TFOX
- Iparomlimab and Tuvonralimab combined with lenvatinib and SOX
- Iparomlimab/Tuvonralimab
- Iparomlimab/Tuvonralimab
- QL1706 (Iparomlimab/Tuvonralimab)
- zlk20251119
Frequently asked questions
What is tuvonralimab?
tuvonralimab is an FDA-listed pharmaceutical active ingredient.